HealthSouth Corp. PT Raised to $42.00 (HLS)
Analysts at Mizuho boosted their price objective on shares of HealthSouth Corp. (NYSE:HLS) from $39.00 to $42.00 in a research report issued to clients and investors on Wednesday, AnalystRatings.Net reports. The firm currently has a “buy” rating on the stock. Mizuho’s price objective points to a potential upside of 21.39% from the stock’s previous close.
Shares of HealthSouth Corp. (NYSE:HLS) traded down 1.45% during mid-day trading on Wednesday, hitting $34.60. 893,995 shares of the company’s stock traded hands. HealthSouth Corp. has a 52 week low of $19.85 and a 52 week high of $37.01. The stock’s 50-day moving average is $35.09 and its 200-day moving average is $31.53. The company has a market cap of $3.021 billion and a P/E ratio of 11.63.
HealthSouth Corp. (NYSE:HLS) last released its earnings data on Tuesday, October 29th. The company reported $0.59 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.41 by $0.18. The company had revenue of $564.00 million for the quarter, compared to the consensus estimate of $557.50 million. During the same quarter last year, the company posted $0.44 earnings per share. HealthSouth Corp.’s revenue was up 5.0% compared to the same quarter last year. On average, analysts predict that HealthSouth Corp. will post $1.86 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 2.08%. The ex-dividend date of this dividend is Monday, December 30th.
Several other analysts have also recently commented on the stock. Analysts at Deutsche Bank raised their price target on shares of HealthSouth Corp. from $33.00 to $36.00 in a research note to investors on Wednesday. They now have a “hold” rating on the stock. Separately, analysts at UBS AG raised their price target on shares of HealthSouth Corp. to $35.50 in a research note to investors on Tuesday. They now have a “neutral” rating on the stock. Finally, analysts at CRT Capital raised their price target on shares of HealthSouth Corp. from $37.00 to $41.00 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $36.56.
HealthSouth Corporation (NYSE:HLS) is an owner and operator of inpatient rehabilitation hospitals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.